Skip to main content

MRNA

Moderna, Inc.

Company with tickers: MRNA

Market Cap
$23.50B
Shares Outstanding
396,786,259
CIK
1682852
CUSIP
60770K107
13F Activity (30d)
55 filings 13 filers
Investor Relations
Investor relations

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Stephen Hoge $18,054,133
James M. Mock $5,857,761
Shannon Thyme $5,397,914
Fiscal 2024
Executive Total
Shannon Thyme Klinger $17,368,701
Shannon Thyme $17,368,701
James M. Mock $17,212,582
Stephen Hoge $9,181,478
Fiscal 2023
Executive Total
Stephen Hoge $7,339,166
James M. Mock $4,317,185
Shannon Thyme Klinger $4,312,496
Shannon Thyme $4,312,496
Fiscal 2022
Executive Total
Stephen Hoge $8,646,652
James M. Mock $7,331,196
Shannon Thyme Klinger $3,721,196
Fiscal 2021
Executive Total
Shannon Thyme Klinger $11,489,147
Corinne Le Goff $10,148,448
Stephen Hoge $7,803,432
Juan Andres $6,603,482
David Meline $5,236,274
Fiscal 2020
Executive Total
David Meline $9,273,960
Stephen Hoge $5,263,296
Tal Zaks $4,252,981
Juan Andres $4,247,823
Lorence Kim $3,393,986
Fiscal 2019
Executive Total
Stephen Hoge $5,001,214
Tal Zaks $4,832,426
Juan Andres $3,862,570
Lorence Kim $3,597,565
Fiscal 2018
Executive Total
Lorence Kim $9,038,117
Stephen Hoge $4,726,274
Fiscal 2017
Executive Total
Stephen Hoge $23,951,977
Lorence Kim $9,315,787